-
Human CD34+ Progenitor Cells from Mobilized Peripheral Blood, Positive Selection, 5 MillionCatalog #: 2Y-101D
Cryopreserved ampule of Human CD34+ Progenitor Cells from Mobilized Peripheral Blood using positive immunomagnetic selection containing ≥ 5 million cells
Sales unit: Ampule -
P3 Primary Cell 4D-Nucleofector® LV Kit XL (5 x 1 RCT)Catalog #: V4LP-3520For larger scale transfection of primary cells, e.g. human T cells or CD34+ hematopoietic stem cells in the LV NucleocuvetteTM Cartridge format when working with the 4D-NucleofectorTM LV UnitSales unit: kit
-
SF Cell Line 4D-Nucleofector® LV Kit XL (5 x 1 RCT)Catalog #: V4LC-2520
For larger scale transfection of cell lines, e.g. suspension CHO or HEK293, in the LV Nucleocuvette® Cartridge format when working with the 4D-Nucleofector® LV Unit
Sales unit: kit -
Human CD34+ Progenitor Cells from Mobilized Peripheral Blood, Positive Selection, 5 Million CellsCatalog #: 4Y-101DCryopreserved ampule of Human CD34+ Progenitor Cells from Mobilized Peripheral Blood using positive immunomagnetic selection containing ≥ 5 million cellsSales unit: each
-
TheraPEAK® P3 Primary Cell Nucleofector® Solution Set (22.5 mL + 5 mL)Catalog #: G4LP3-22500
For use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.
Sales unit: items -
Fresh Human Leukopak - Neupogen(R) Mobilized (Day 6 Collection, Full Bag)Catalog #: 3Y-300BFresh human leukopheresis product collected from peripheral blood mobilized with Neupogen(R) 10 mcg/kg/day x 5 days, Second Collection, Day 6, 1 BagSales unit: each
-
MsGMTM Mesangial Cell Growth Medium BulletKit®Catalog #: CC-3146
Culture system containing MsGMTM Mesangial Basal Medium (CC-3147) and MsGMTM SingleQuots® Supplements (CC-4146) required for growth of human mesangial cells.
Sales unit: kit -
-
LAL Reagent Grade 96-well PlatesCatalog #: 00313405
96-well plates intended for use with LAL-based endotoxin assays
Sales unit: each -
SCGMTM Stromal Cell Growth Medium BulletKit®Catalog #: CC-3205
SCGMTM Stromal Cell BulletKit®
Sales unit: kit
-
Primary Human Hepatocyte 3D Spheroids Co-cultured with Non-Parenchymal CellsHigh Throughput Meets Physiological Relevence
-
WinKQCL™ Endotoxin Detection and Analysis Software - Meeting Your Data Integrity Needs Globally!WinKQCL-Meeting Your Data Integrity Needs.pdf
-
DISCO User Meeting AgendaDetailed speaker, presentation, and time slot data for the 2021 drug discovery user meeting
-
Lonza Agarose Series: Meet the Team
Innovation, expertise and know-how of agarose are part of the DNA of the team in Rockland, Maine (US). Research and development, manufacturing and quality control go hand-in-hand to produce the fine agarose products you use in the research laboratory. Meet the team behind our agarose and listen to their stories.
-
CellBio Services – Custom Solutions to Meet Your Unique Research NeedsBrochure showcasing Lonza's CellBio Services capabilities including cell isolations and expansions, research grade media production, transfection services, and cell characterization.
-
2019 Global Endotoxin Testing Summit Agenda, Where Science Meets InspirationDownload Agenda
-
People behind the Product Video: Meet Travis Wallace
-
People behind the Product Video: Meet Travis Wallace, Lonza WalkersvilleSenior Scientific Support Specialist for Lonza endotoxin testing, a troubleshooter and musician who loves the aspect of training in his daily work. Learn about Travis’ contribution to our QC Testing Solutions group, and the rewarding aspects of his job.
-
Meet the Experts: Introducing the GSv9™ Media and Feeds for Lonza’s GS System®Join us and meet Colin Jaques, Ph.D. Technical Director, Lonza Biologics and Faraz Harsini, Ph.D., Protein Expression and Process Development Scientist, XBiotech USA Inc. to learn about Lonza’s GSv9™ Media and Feeds designed to optimize your GS System® performance.
-
MODA® Nephron Case Study - Developing an Electronic Batch Record Solution That Meets Pharmaceutical Manufacturers’ NeedsHow Lonza worked with pharmaceutical manufacturer Nephron Pharmaceuticals to develop and implement the MODA-ES® Platform in an accelerated timeframe.